Aastrom Biosciences, Inc. (ASTM) To Present At The 2013 Therapeutic Area Partnerships Conference
11/12/2013 1:18:48 PM
ANN ARBOR, Mich., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that Nick Colangelo, President and CEO of Aastrom, will present at the 2013 Therapeutic Area Partnerships Conference on Tuesday, November 19 at 4:30 p.m. EST at the Hyatt Regency in Boston, MA. The conference organizers have selected ixmyelocel-T as a Top Project to Watch in advanced therapies.
Help employers find you! Check out all the jobs and post your resume.
comments powered by